Please assess the completion status of the following clinical trial:

Trial Title: Magnetic Resonance Diabetic Cardiac Stress Imaging

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
INCLUSION CRITERIA:~* Patient older than 18 years old~* Patient with health care coverage ( social security or universal health coverage - CMU)~* Patient who had a prior medical examination~* Diabetic patient (type 1 or type 2) with no known coronary artery disease, addressed for myocardial scintigraphy~* Patient who was informed of objectives and constraints of the study and having given his consent in writing~EXCLUSION CRITERIA:~* Pregnant and lactating women~* Patients with known coronary disease (myocardial infarction, unstable angina, history of coronary artery disease)~* Patient with contra-indication for MRI claustrophobia, metallic foreign body in the eye, pacemakers, mechanical heart valve laid before 1985 Patient with specific contra-indication to vasodilators~* Severe hypotension \< 90 mmHg~* Hypersensitivity to adenosine or dipyridamole~* Bronchial asthma, chronic obstructive pulmonary disease with obvious bronchospasm. Severe and known pulmonary artery hypertension~* Atrioventricular 2nd or 3rd degree blocks, long QT syndrome~* Tight known carotid artery stenosis (70% NASCET criterion), with no possible vascular substitution~* Patient with contra-indication to cardiac stimulation~* Unstable hemodynamic state and / or unstable angina not stabilized by drug treatment and/or decompensated or severe heart failure~* Known comorbidities : pregnancy and lactation, tight aortic valve or mitral valve stenosis, severe left-right shunt, severe pericarditis or abundant pericardial effusion~* Contra-indication to coronary angiography~* Renal failure with creatinine clearance \< 30 ml / min~* Hypersensitivity to contrast agents that resulted in a serious complication

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): MRI = Myocardial Perfusion Stress and MPS = Myocardial Perfusion Scintigraphy~* Diabetic patients~* Coronary insufficiency

Based on this trial design, predict the completion outcome and termination type (if applicable).